The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment of adult ...

Gene therapy can effectively treat various diseases, but for some debilitating conditions like muscular dystrophies there is ...

StitchR, a new gene therapy technique, delivers large genes in two parts to treat muscular dystrophies by restoring critical proteins in animal models.

Inovio Pharmaceuticals ( INO -3.64%) Q3 2024 Earnings Call Nov 14, 2024, 4:30 p.m. ET ...

With over 100 publications in international journals, his groundbreaking work has earned him ... In 2014, he founded VectorBuilder, a revolutionary online platform for vector design and ordering that ...

One of the most interesting enrollment trends at the University of Wisconsin in recent history has been the shift toward accommodating an ever-larger population of out-of-state students. Currently, UW ...

Good afternoon, and welcome to Fractyl Health's Third Quarter Financial Results and Business Updates Call. As a reminder, this conference call is being recorded. [Operator Instructions]. I will now ...

Avantor, Inc. , a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced the opening of its new ...

QLSTM, a hybrid quantum-classical model, excels in stock price prediction, achieving a 50% RMSE reduction and 10% accuracy ...

Gene therapy can effectively treat various diseases, but for some debilitating conditions like muscular dystrophies there is a big problem: size.

Innovative urinary miRNA profiling shows potential for early pancreatic cancer detection, with high accuracy and sensitivity, ...

The increasing global prevalence of vector-borne diseases, such as malaria, dengue, yellow fever, and other viral infections ...